Viewing Study NCT02371967


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-02-18 @ 10:39 AM
Study NCT ID: NCT02371967
Status: COMPLETED
Last Update Posted: 2020-10-09
First Post: 2015-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module